[Business Wire] - Idera Pharmaceuticals today announced the pricing of an underwritten public offering by Idera Pharmaceuticals of for a combined public offering price of $0.50 per share of common stock and related warrant, 17,500,000 shares of common stock and related warrants to purchase up to 17,500,000 shares of common stock at an exercise price of $0.47 per share, and for a combined public offering price of $0.49 ...
No comments:
Post a Comment